Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infection.

Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infection. - Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infection.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047184

Enrollment

100

Registered

2022-03-16

Start date

2020-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients admitted to the National Center for Global Health and Medicine Hospital with COVID-19 from February 1 to April 30, 2020

Exclusion criteria

Exclusion criteria: Cases in which corticosteroids were not used in doses consistent with ARDS or severe pneumonia

Design outcomes

Primary

Measure	Time frame
Improved scores for 7-category ordinary scale	—

Countries

Japan

Contacts

Public ContactChie morita

Center Hospital of the National Center for Global Health and Medicine Department of Respiratory medicine

cmorita@hosp.ncgm.go.jp0332027181

Outcome results